Matthew Brams
EVP and Chief Medical Officer · Cingulate Inc.
- 2024
- Jul 20, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Brams files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas Jeffrey Hargroves - $498K in CING purchases and sales in the last 12 months
- Peter J. Werth - $100K in CING purchases and sales in the last 12 months
- Shane J. Schaffer - $35K in CING purchases and sales in the last 12 months
- Jennifer L. Callahan - $25K in CING purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew Brams?
Matthew Brams is a corporate insider, tracked as EVP and Chief Medical Officer of Cingulate Inc. (CING). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Matthew Brams last file a Form 4?
The most recent primary Form 4 on record is dated 20 July 2026, one of 5 filings going back to 2024.
Has Matthew Brams been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
